Zero-order drug delivery: State of the art and future prospects

ML Laracuente, HY Marina, KJ McHugh - Journal of Controlled Release, 2020 - Elsevier
Pharmaceutical drugs are an important part of the global healthcare system, with some
estimates suggesting over 50% of the world's population takes at least one medication per …

[HTML][HTML] Osmotic pump drug delivery systems—a comprehensive review

Y Almoshari - Pharmaceuticals, 2022 - mdpi.com
In the last couple of years, novel drug delivery systems (NDDS) have attracted much
attention in the food and pharmaceutical industries. NDDS is a broad term that …

[BOOK][B] Oral controlled release formulation design and drug delivery: theory to practice

H Wen, K Park - 2011 - books.google.com
This book describes the theories, applications, and challenges for different oral controlled
release formulations. This book differs from most in its focus on oral controlled release …

Development of Budesonide Microparticles Using Spray-Drying Technology for Pulmonary Administration: Design, Characterization, In Vitro Evaluation, and In Vivo …

SR Naikwade, AN Bajaj, P Gurav, MM Gatne… - AAPS …, 2009 - Springer
The purpose of this research was to generate, characterize, and investigate the in vivo
efficacy of budesonide (BUD) microparticles prepared by spray-drying technology with a …

Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release …

W Xiang, YQ Sun, HC Teoh - Drug design, development and …, 2018 - Taylor & Francis
Background Nocturnal symptoms are common in Parkinson's disease (PD), which greatly
affect the quality of life but are often overlooked in clinical settings. Treatment strategies that …

Development and In Vitro/In Vivo Evaluation of Etodolac Controlled Porosity Osmotic Pump Tablets

A Abd-Elbary, MI Tadros, AA Alaa-Eldin - AAPS PharmSciTech, 2011 - Springer
The aim of the current work was the design and evaluation of etodolac controlled porosity
osmotic pump (CPOP) tablets exhibiting zero-order release kinetics. Variables influencing …

[PDF][PDF] Development of time and pH dependent controlled release colon specific delivery of tinidazole

SR Naikwade, PP Kulkarni, SR Jathar, AN Bajaj - 2008 - sid.ir
Purpose: Tinidazole is used in treatment of amoebiasis and other protozoal infections in
doses of 2.0 g/day (60 mg/kg) for three days. In the present paper, controlled release …

[PDF][PDF] Once a day osmotic drug delivery system for highly water soluble Pramipexole

W Rajeshri, A Bajaj - J Chem Pharm Res, 2010 - academia.edu
An oral monolithic osmotic system for highly water-soluble pramipexole dihydrochloride
monohydrate has been developed and characterized. Monolithic osmotic system was …

Push-pull osmotic pump for zero order delivery of lithium carbonate: Development and in vitro characterization

V Patel, A Chudasama, M Nivsarkar… - Pharmaceutical …, 2012 - Taylor & Francis
Lithium carbonate, a drug with narrow therapeutic index, needs therapeutic drug monitoring
and dose adjustment to maintain lithium level within the therapeutic window. Conventional …

Model drug as pore former for controlled release of water-soluble metoprolol succinate from ethylcellulose-coated pellets without lag phase: opportunities and …

Y Wang, J Dai, X Chang, M Yang, R Shen, L Shan… - AAPS …, 2015 - Springer
The objective of the present study was to evaluate the feasibility of using model drug
metoprolol succinate (MS) as a pore former to modify the initial lag phase (ie, a slow or non …